A retrospective comparison of respiratory events with JAK inhibitors or rituximab for rheumatoid arthritis in patients with pulmonary disease. (2021)

First Author: Cronin O
Attributed to:  MICA: A new paradigm for testing pathway tractability in lung disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00296-021-04835-1

PubMed Identifier: 33721094

Publication URI: http://europepmc.org/abstract/MED/33721094

Type: Journal Article/Review

Volume: 41

Parent Publication: Rheumatology international

Issue: 5

ISSN: 0172-8172